Literature DB >> 24945079

Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression.

Z Zhao1, X Jiang, C Kang, Y Xiao, C Hou, J Yu, R Wang, H Xiao, T Zhou, Z Wen, J Feng, G Chen, Y Ma, B Shen, Y Li, G Han.   

Abstract

Sepsis is a life-threatening condition, but the pathophysiological basis and biomarkers for the monitoring of sepsis and as targets for therapy remain to be determined. We have shown previously that T cell immunoglobulin and mucin domain protein 3 (Tim-3), a negative immune regulator, is involved in the physiopathology of sepsis, but the underlying mechanisms remain unclear. In the present study, we showed that Tim-3 signalling modulated the response patterns of both macrophages and T helper cells in sepsis. Blockade of the Tim-3 pathway exacerbated sepsis-induced proinflammatory macrophage responses and lymphocyte apoptosis during the early phase of sepsis, and enhanced the shift to anti-inflammatory responses for both macrophages and T helper cells during the late phase of sepsis. Tim-3 signalling was found to regulate CD80 and CD86 expression on macrophages both in vivo and in vitro. Co-culture of T cells with Tim-3 knock-down macrophages led to a biased T helper type 2 (Th2) response, partially explaining how Tim-3 signalling shapes inflammation patterns in vivo. Further studies on this pathway might shed new light on the pathogenesis of sepsis and suggest new approaches for intervention.
© 2014 British Society for Immunology.

Entities:  

Keywords:  T helper cell; Tim-3; macrophage; sepsis

Mesh:

Substances:

Year:  2014        PMID: 24945079      PMCID: PMC4233378          DOI: 10.1111/cei.12401

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Blockade of Tim-3 signaling restores the virus-specific CD8⁺ T-cell response in patients with chronic hepatitis B.

Authors:  Wei Wu; Yu Shi; Shuping Li; Yun Zhang; Yanning Liu; Yihua Wu; Zhi Chen
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

Review 2.  Extrinsic and intrinsic control of macrophage inflammatory responses.

Authors:  Heather B Cohen; David M Mosser
Journal:  J Leukoc Biol       Date:  2013-08-20       Impact factor: 4.962

3.  The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.

Authors:  Rodrigo Liberal; Charlotte R Grant; Beth S Holder; Yun Ma; Giorgina Mieli-Vergani; Diego Vergani; Maria Serena Longhi
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

4.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Response of lung NK1.1-positive natural killer cells to experimental sepsis in mice.

Authors:  Mark Hirsh; Viktoria Kaplan; Larissa Dyugovskaya; Michael M Krausz
Journal:  Shock       Date:  2004-07       Impact factor: 3.454

Review 6.  Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.

Authors:  Parris Kidd
Journal:  Altern Med Rev       Date:  2003-08

7.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

Review 8.  Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies.

Authors:  Fabienne Venet; Anne-Claire Lukaszewicz; Didier Payen; Richard Hotchkiss; Guillaume Monneret
Journal:  Curr Opin Immunol       Date:  2013-05-28       Impact factor: 7.486

9.  Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis.

Authors:  Fengmin Shi; Xiaoqin Guo; Xingwei Jiang; Ping Zhou; Yan Xiao; Tingting Zhou; Guojiang Chen; Zhi Zhao; He Xiao; Chunmei Hou; Xinying Li; Xiaomei Yang; Renxi Wang; Jiannan Feng; Beifen Shen; Yan Li; Gencheng Han
Journal:  Clin Immunol       Date:  2012-09-18       Impact factor: 3.969

Review 10.  Sepsis induced immunosuppression: Implications for secondary infections and complications.

Authors:  Krishna M Sundar; Mazen Sires
Journal:  Indian J Crit Care Med       Date:  2013-05
View more
  10 in total

Review 1.  Sepsis and septic shock.

Authors:  Richard S Hotchkiss; Lyle L Moldawer; Steven M Opal; Konrad Reinhart; Isaiah R Turnbull; Jean-Louis Vincent
Journal:  Nat Rev Dis Primers       Date:  2016-06-30       Impact factor: 52.329

2.  Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells.

Authors:  Siyuan Huang; Di Liu; Jianhui Sun; Huacai Zhang; Jing Zhang; Qiang Wang; Lebin Gan; Guoxin Qu; Jinchao Qiu; Jin Deng; Jianxin Jiang; Ling Zeng
Journal:  Mol Ther       Date:  2021-12-18       Impact factor: 11.454

3.  Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis.

Authors:  Xingwei Jiang; Tingting Zhou; Yan Xiao; Jiahui Yu; Shuaijie Dou; Guojiang Chen; Renxi Wang; He Xiao; Chunmei Hou; Wei Wang; Qingzhu Shi; Jiannan Feng; Yuanfang Ma; Beifen Shen; Yan Li; Gencheng Han
Journal:  Oncoimmunology       Date:  2016-08-03       Impact factor: 8.110

Review 4.  Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.

Authors:  Hiroyuki Horiguchi; Tyler J Loftus; Russell B Hawkins; Steven L Raymond; Julie A Stortz; McKenzie K Hollen; Brett P Weiss; Elizabeth S Miller; Azra Bihorac; Shawn D Larson; Alicia M Mohr; Scott C Brakenridge; Hironori Tsujimoto; Hideki Ueno; Frederick A Moore; Lyle L Moldawer; Philip A Efron
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 5.  Targeting Immune Cell Checkpoints during Sepsis.

Authors:  Naeem K Patil; Yin Guo; Liming Luan; Edward R Sherwood
Journal:  Int J Mol Sci       Date:  2017-11-14       Impact factor: 5.923

Review 6.  Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis.

Authors:  Chao Cao; Muming Yu; Yanfen Chai
Journal:  Cell Death Dis       Date:  2019-10-14       Impact factor: 8.469

7.  Early detection of soluble CD27, BTLA, and TIM-3 predicts the development of nosocomial infection in pediatric burn patients.

Authors:  Julia A Penatzer; Robin Alexander; Shan Simon; Amber Wolfe; Julie Breuer; Josey Hensley; Renata Fabia; Mark Hall; Rajan K Thakkar
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

8.  Galectin-9 Alleviates LPS-Induced Preeclampsia-Like Impairment in Rats via Switching Decidual Macrophage Polarization to M2 Subtype.

Authors:  Zhi-Hui Li; Li-Ling Wang; Hong Liu; Kahinho P Muyayalo; Xiao-Bo Huang; Gil Mor; Ai-Hua Liao
Journal:  Front Immunol       Date:  2019-01-10       Impact factor: 7.561

9.  TIM-3 Genetic Variants Are Associated with Altered Clinical Outcome and Susceptibility to Gram-Positive Infections in Patients with Sepsis.

Authors:  Caspar Mewes; Tessa Alexander; Benedikt Büttner; José Hinz; Ayelet Alpert; Aron-F Popov; Michael Ghadimi; Tim Beißbarth; Mladen Tzvetkov; Marian Grade; Michael Quintel; Ingo Bergmann; Ashham Mansur
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

Review 10.  Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.

Authors:  Margaret A McBride; Tazeen K Patil; Julia K Bohannon; Antonio Hernandez; Edward R Sherwood; Naeem K Patil
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.